Latest news with #AAV
Time of India
a day ago
- Sport
- Time of India
Sam Bennett declares 'Ain't f****** leaving' after Stanley Cup win, hints at staying with Panthers despite no official deal
Sam Bennett gives Panthers fans hope with bold promise to stay (Image via: Getty Images) 'Ain't f—ing leaving.' That's how Sam Bennett delivered what might be the biggest offseason headline for Florida Panthers fans. Fresh off back-to-back Stanley Cup championships, the Panthers' Conn Smythe-winning forward signaled to a roaring crowd in Miami that he's not planning to leave, even as his contract ticks toward free agency on July 1. Sam Bennett 's declaration sparks hope for Panthers fans During Thursday night's Stanley Cup celebration in downtown Miami, Sam Bennett stood center stage with teammate Sam Reinhart and told the crowd what every Florida fan wanted to hear: he's staying. The Panthers' gritty, relentless forward has become a cornerstone of the team's identity and his fiery words added fuel to a city already buzzing with championship energy. But there's a twist. By Friday morning, Bennett's agent, Darren Ferris, clarified that no new contract has been signed. 'The celebrations have been amazing to see, and Sam's just taking it all in with his teammates,' Ferris said. 'At this time, no contract has been signed — when there's something official, we'll share it accordingly.' Panthers' Sam Bennett Awarded 2025 Conn Smythe Trophy As Playoffs MVP Panthers general manager Bill Zito has expressed confidence in bringing back all three of the team's key free agents: Sam Bennett, Brad Marchand, and Aaron Ekblad. And with Bennett recently earning the Conn Smythe Trophy as playoff MVP, there's no doubt he's due for a significant pay raise. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Costco Shoppers Say This Wrinkle Cream Is "Actually Worth It" The Skincare Magazine Undo Bennett, who just turned 29, is coming off a four-year deal worth $4.425 million per season. Comparable forwards like Matt Duchene have already set the market with a $4.5 million AAV, making Bennett's next contract a major talking point this offseason. As for other potential suitors, don't bet on the Toronto Maple Leafs landing Bennett—despite needing a player with his fire and grit. Reports suggest Bennett has no interest in signing with Toronto, even if he hits free agency. Also Read: Florida Panthers Parade 2025: Date, Time, Route and How fans can celebrate Stanley Cup win Sam Bennett's message showed his deep connection to the Florida Panthers and their fans. He's the kind of player who plays with heart, grit, and loyalty—everything South Florida loves. Now, all eyes are on the front office to make his return official. Game On Season 1 kicks off with Sakshi Malik's inspiring story. Watch Episode 1 here
Business Wire
2 days ago
- Health
- Business Wire
Clinical Milestones, Vector Innovation Key to Gene Therapy, GenoTher Biocluster's First International Summit,
PARIS--(BUSINESS WIRE)--Genethon, a unique non-profit gene therapy R&D organization founded by the French Muscular Dystrophy Association (AFM-Telethon), and its spin-off Atamyo Therapeutics made significant advances in their gene therapies for multiple rare diseases as highlighted in Genethon's most recent Newsletter. Chief among them are key clinical milestones reached, including those reflected in Genethon's Phase 3 ready Duchene muscular dystrophy gene therapy (GNT0004); and Atamyo's significant milestones in clinical trials of gene therapies (ATA-100 and ATA-200) for treatment of two subtypes of limb-girdle muscular dystrophy (LGMD2I/R9 and LGMD2C/R5). In addition, the GenoTher Biocluster, a public-private partnership serving as a leading ecosystem for generation of innovative genetic medicines' approaches, held its first international summit attended by 350 researchers, investors, biotech executives and public decision-makers representing more than 100 organizations. In his CEO Commentary, Genethon's Frederic Revah discusses new research involving the organization's AAV platform to increase safety, efficacy and disease applications of gene therapies. Dr. Revah reports Genethon also is exploring non-viral based delivery systems, such as Lipid Nano Particles (LNPs), for their potential in gene editing. Atamyo in April completed the dose escalation phase of a Phase 1b/2b trial in Europe of ATA-100 for LGMD2I/R9 and announced in June dosing in the US of the first two patients in a Phase 1b/2 study of ATA-200 for LGMD2C/R5. Both subtypes lead to loss of ambulation and other complications in children and there are no cures. Read the full Newsletter to learn about these gene therapy advances and others. About Genethon As a pioneer in the discovery and development of gene therapies for rare diseases, Genethon is a non-profit laboratory that was established by AFM-Telethon. A first gene therapy for spinal muscular atrophy to which Genethon contributed has obtained a product license. With more than 200 scientists and professional staff, Genethon is pursuing its aim to develop therapies which change the lives of patients suffering from rare genetic diseases. Thirteen products stemming from Genethon's R&D or from collaborations are in clinical trial for diseases of the liver, blood, immune system, muscles and eyes. Seven other products could enter clinical trials over the next five years. More information at
New York Post
3 days ago
- Sport
- New York Post
Where Rangers' salary-cap situation stands after Matt Rempe signing
The Matt Rempe Experience will roll on at the Garden next year with bigger — well — and better expectations for this unique hockey weapon who improved steadily over the course of the second half of the season. Access the Rangers beat like never before Get Mollie Walker's text messages with the latest Rangers buzz and get your questions answered — exclusive to Sports+ subscribers. SIGN UP NOW The Rangers took care of business with the pending restricted free agent winger, signing Rempe to a two-year deal with an AAV of $975,000 per before he could become offer-sheet eligible on July 1, The Post first reported Wednesday morning. This leaves the Blueshirts with approximately $14.5 million in cap space off an 18-player shadow roster that does not include pending Group II's Will Cuylle, K'Andre Miller, Adam Edstrom, Zac Jones, Matt Robertson and Arthur Kaliyev. If one does the math — which the hierarchy does just about on the hour every single day — it is all but impossible to understand where the rampant rumors of the Rangers preparing offer sheets originated and why this continues to be circulated on internet-land.
Straits Times
3 days ago
- Business
- Straits Times
US defence firms chase European military spending wave
FILE PHOTO: An Anduril Industries Fury autonomous air vehicle (AAV) is displayed at the 55th International Paris Airshow at Le Bourget Airport near Paris, France, June 17, 2025. REUTERS/Benoit Tessier/File Photo PARIS - U.S. defence giants, backed by a strong Congressional delegation from Washington, used the Paris Airshow to showcase cutting-edge technologies and court European partners as they seek to tap into rising regional military spending. Many European nations have pledged to significantly increase defence budgets in response to Russia's invasion of Ukraine and as U.S. President Donald Trump's administration has threatened to scale back military support for the region. That tension has been notably absent at this week's Paris Airshow, where U.S. lawmakers and arms manufacturers pledged greater transatlantic partnership as Europe ramps up spending on everything from artillery shells and fighter jets to missile defence systems. "We understand that our allies and partners are a force multiplier, so we are stronger when we are working together," U.S. Senator Jerry Moran, a member of Trump's Republican party, told reporters at the show, the world's largest aerospace and defence gathering. Moran, whose delegation was supporting U.S. weapons makers, said it was in Paris to send a message that the U.S. "is a dependable and reliable partner". The conciliatory tone stands in stark contrast to the Trump administration's recent string of disparaging remarks about Europe and its defence industry. "I think antagonising our allies does not make us stronger," Democrat Senator Jeanne Shaheen told reporters in Paris, expressing her desire to cement defence relations with Europe. RELIANCE ON U.S. Despite pledges by many European nations to boost military self-sufficiency, the continent remains heavily reliant on U.S. defence manufacturers. For instance, Europe buys American-made fighter jets and missiles from Lockheed Martin, Patriot missile defence systems from Raytheon Technologies and military jets and helicopters built by Boeing. In emerging military areas, like artificial intelligence, drones and satellite constellations, U.S. tech firms like Anduril, Palantir and Elon Musk's SpaceX are far ahead. U.S. firms are hoping to press home their advantage as European military spending surges, including through partnerships which are a way to soften any potential diplomatic tensions, delegates said. U.S. drone-maker Anduril and German defence giant Rheinmetall said on Wednesday they will link up to build military drones for European markets, in a sign of Europe leveraging American technology to boost military capabilities. Thomas Laliberty, president of Land & Air Defense Systems at Raytheon, said there were no easy replacements for its weapons in Europe and he expected the firm to maintain a long-term footprint on the continent, including through new partnerships. Laliberty said Raytheon was close to announcing a plan to manufacture Stingers - a lightweight air defence missile used by Ukrainian forces against Russia - in Europe. "For immediate needs, Raytheon is well positioned to support the European demand," Laliberty told reporters in Paris. "We have a very bright future here." Boeing, which won a contract from Trump's administration to develop the next-generation F-47 fighter jet this year, said Europe and the U.S. would remain long-term partners despite political wobbles, partly to hold off the Chinese threat. "Nobody can do it themselves - maybe the Chinese can try, but certainly the rest of us, we are going to have to work together," said Turbo Sjogren, Boeing's general manager for government services. "To do otherwise takes too long and will be unaffordable." The chairman of Italian aerospace and defence group Leonardo, Stefano Pontecorvo, added that U.S. participation in some European programmes would be "unavoidable" in coming years due to the defence technologies available to them. EUROPE TOO SLOW European rivals were bullish about their future growth prospects but said budget constraints and a lack of regional alliances were holding back progress, conceding that they would continue to need significant U.S. support. "National sovereignty matters but fragmentation is detrimental. We need to find a way to hit a balance," Leonardo CEO Roberto Cingolani told reporters on Tuesday. Jean-Brice Dumont, head of air power, defence and space at Airbus, said Europe's dependence on the U.S. was "very high". "Zero dependency on the U.S. I believe is a dream. We have a need for interoperability that drives some U.S. needs," said Dumont, whose firm makes the Eurofighter Typhoon fighter jet with Britain's BAE Systems and Italy's Leonardo, as well as Earth observation satellites and drones. Italian Defence Minister Guido Crosetto said Europe had "too much bureaucracy" compared to the U.S. and needed to adapt to a new military era of faster, cheaper and more nimble technology. "Either Europe adapts its industry to these new parameters - different from those with which it has lived until four years ago - or it will have huge competitors, and not only the American ones," he said. REUTERS Join ST's Telegram channel and get the latest breaking news delivered to you.
Yahoo
5 days ago
- Sport
- Yahoo
East Playoff Team Expected to Take 'Massive Swing' at Signing Mitch Marner
East Playoff Team Expected to Take 'Massive Swing' at Signing Mitch Marner originally appeared on Athlon Sports. Mitch Marner has spent his entire nine-year NHL career with the Toronto Maple Leafs. The Markham, Ontario, native was drafted fourth overall by his hometown team in 2015 and has given everything to the franchise, recording 221 goals, 520 assists and 741 points. Advertisement However, since entering the league in the 2016-17 NHL season, the Leafs have made it past the first round of the Stanley Cup playoffs only twice, losing both times in the second round. A big change is needed to get over the hump. With Marner's six-year contract set to expire this summer, all signs point to him leaving the organization. Toronto Maple Leafs forward Mitch Marner (16).Dan Hamilton-Imagn Images With July 1 nearing quickly, The Fourth Period's David Pagnotta revealed that the Carolina Hurricanes are one team expected to take a "massive swing" at signing Marner if the Leafs officially decide to let him walk. "When/if Mitch Marner hits the open market July 1, the expectation is the Carolina Hurricanes are going to take a massive swing to try and sign him," Pagnotta said. "Sources say we shouldn't be surprised if they go above $14M on an AAV over a 7-year term. UFA market opens in 18 days." Advertisement The Hurricanes are coming off their second Eastern Conference Final appearance in the past three seasons, but it's clear they need more to reach the Stanley Cup Final. Across nine conference final games in those two playoff runs, they are 1-8. That's not going to cut it, but adding a player like Marner could be the answer. Raleigh is a much smaller market compared to Toronto, and he won't be under the microscope like he was in his hometown. Related: Potential NHL Expansion City Makes Big Move Toward Securing Team Wednesday Related: Maple Leafs Fans Buzzing After First Big Move of Offseason This story was originally reported by Athlon Sports on Jun 13, 2025, where it first appeared.
